NYSE:LLY Eli Lilly and Company Q3 2026 Earnings Date & Estimates $1,279.29 +5.83 (+0.46%) Closing price 03:59 PM EasternExtended Trading$1,280.90 +1.62 (+0.13%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Eli Lilly and Company is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. The conference call is scheduled for 10:00 AM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateOctober 29, 2026TimeBefore Market OpensConference Call10:00 AM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Eli Lilly and Company in Q3 2026Eli Lilly and Company is expected to post earnings of $5.70 per share on revenue of $22.58 billion. In the same quarter a year earlier Eli Lilly and Company reported $7.02 per share on revenue of $17.60 billion. Eli Lilly and Company last reported on August 5, 2026, posting $8.38 per share and beating the $6.40 consensus estimate. Eli Lilly and Company has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS$5.70Expected Revenue$22.58 billionPrior-Year EPS$7.02Prior-Year Revenue$17.60 billionExpected EPS Growth-18.8%Expected Revenue Growth+28.3%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$8.38 (Beat by +$1.98)Last Quarter Revenue$22.97 billionEPS Beat Rate5 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Eli Lilly and Company Q3 2026 Earnings FAQ When does Eli Lilly and Company report Q3 2026 earnings? Eli Lilly and Company (NYSE:LLY) is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Eli Lilly and Company's Q3 2026 earnings call? Eli Lilly and Company's Q3 2026 earnings conference call is scheduled for Thursday, October 29, 2026 at 10:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Eli Lilly and Company? Analysts expect Eli Lilly and Company to post earnings of $5.70 per share for Q3 2026. How much revenue is Eli Lilly and Company expected to report? The consensus revenue estimate for Eli Lilly and Company is $22.58 billion for Q3 2026. Eli Lilly and Company Earnings HeadlinesBernstein Adjusts Price Target on Eli Lilly and Company to $1,450 From $1,38559 minutes ago | finance.yahoo.comUS judge won't block Eli Lilly ads for weight-loss drugs, rules against Novo NordiskOctober 26 at 5:30 PM | msn.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 26 at 1:00 AM | Banyan Hill Publishing (Ad)Wall Street Has High Expectations for Eli Lilly Stock (LLY) Heading into EarningsOctober 26 at 4:10 PM | tipranks.comDear Eli Lilly Stock Fans, Mark October 29 on Your CalendarOctober 26 at 1:31 PM | barchart.comLilly (LLY) Q3 Earnings Preview: What You Should Know Beyond the Headline EstimatesOctober 26 at 12:29 PM | finance.yahoo.comSee More Eli Lilly and Company Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Eli Lilly and Company? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eli Lilly and Company and other key companies, straight to your email. Email Address About Eli Lilly and CompanyEli Lilly and Company (NYSE:LLY) (NYSE: LLY) is a global pharmaceutical company that discovers, develops, manufactures and markets medicines for a range of medical conditions. Its major therapeutic areas include diabetes and obesity, oncology, immunology, neuroscience and cardiovascular health. The company’s portfolio includes Mounjaro and Trulicity for diabetes, Zepbound for chronic weight management, Humalog insulin, Taltz for inflammatory diseases, Verzenio for certain breast cancers and Kisunla for early symptomatic Alzheimer’s disease. Lilly also develops medicines for migraine, depression and other neurological conditions, and maintains a pipeline of treatments in clinical development. Founded in 1876 by Colonel Eli Lilly, the company is headquartered in Indianapolis, Indiana. Lilly serves patients and healthcare providers through operations and commercial activities in numerous countries worldwide. David A. Ricks is the company’s chair and chief executive officer.View Eli Lilly and Company ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Anthropic's IPO Filing Reveals a Massive Opportunity for AI Infrastructure GiantsBristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own StockBuy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big CatalystsComfort Systems Earnings: AI Slowdown or More Growth Ahead?MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline Upcoming Earnings Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Baker Hughes (10/27/2026)ONEOK (10/27/2026)Robinhood Markets (10/27/2026)HSBC (10/27/2026)S&P Global (10/27/2026)Visa (10/27/2026)HCA Healthcare (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
